QNRX insider trading
NasdaqCM HealthcareQuoin Pharmaceuticals, Ltd.: insider trade history from SEC Form 4 filings.
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Company website: quoinpharma.com
QNRX insider activity at a glance
FilingIQ tracks 25 insider transactions for QNRX in filings since Jun 10, 2024. The most recent transaction is dated Aug 31, 2026.
Across the full history, 22 open-market purchases
and 1 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest QNRX Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for QNRX?
- FilingIQ tracks 25 Form 4 insider transactions for QNRX (Quoin Pharmaceuticals, Ltd.), covering filings from Jun 10, 2024 onwards. 6 of those are dated within the last 90 days.
- Are QNRX insiders net buyers or net sellers?
- Across the full Form 4 history for QNRX, 22 transactions (88%) were open-market purchases and 1 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does QNRX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is QNRX in?
- Quoin Pharmaceuticals, Ltd. (QNRX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $14.58M.
Methodology & sources
Every QNRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.